Clinical Trials on CYP3A Inhibitor
Total 535 results
-
University of TurkuTurku University Hospital; Sanofi; Vaasa Central Hospital, Vaasa, Finland; medbase...CompletedCYP3A Phenotyping | CYP3A5 and MDR1 Genotyping | Docetaxel Toxicity | Associations Between Genetic Data and Docetaxel ToxicityFinland
-
Jazz PharmaceuticalsCompletedEvaluation of Pharmacokinetics of Sativex in the Absence and Presence of a Known Inducer of CYP3A4 | Evaluation of Pharmacokinetics of Sativex in the Absence and Presence of a Potent Inhibitor of CYP3A4 | Evaluation of Pharmacokinetics of Sativex in the Absence and Presence of a CYP2C19...United Kingdom
-
University Hospital, Basel, SwitzerlandCompletedCytochrome P450 CYP3A Enzyme DeficiencySwitzerland
-
Washington University School of MedicineNational Institute of General Medical Sciences (NIGMS)CompletedEvaluate Two Paradigms for Simultaneous Assessment of Hepatic and Intestinal CYP3AUnited States
-
Karolinska University HospitalAstraZenecaCompleted
-
University of Michigan Rogel Cancer CenterWithdrawn
-
Johns Hopkins UniversityCompletedHealthy Subjects | Cytochrome P450 CYP3A5 Enzyme Polymorphism | Pharmacokinetics of MaravirocUnited States
-
Groupe Hospitalier Paris Saint JosephCompleted
-
German Cancer Research CenterUniversity Hospital HeidelbergRecruitingPancreatic Cancer | Pancreatic Adenocarcinoma | CYP3A Inhibitor | Advanced Stage or Metastatic Pancreatic Ductal Adenocarcinoma | Pancreatic NeoplasmGermany
-
PfizerCompletedPharmacokinetics | Cytochrome P-450 CYP2D6 | CYP3A4 Protein, HumanUnited States
-
Inje UniversityCompletedHealthy Subjects | Pharmacokinetics of Three PDE5Is | Genetic Polymorphic CYP3A5
-
Nanjing Medical UniversityCompletedImmune Checkpoint Inhibitor | Endocrine ToxicityChina
-
Groupe Hospitalier Paris Saint JosephCompletedProton Pump InhibitorFrance
-
Meir Medical CenterUnknownThe Combined Effect of Hsp90 Inhibitor and HDAC/Proteasome Inhibitors on Lung Cancer Cell Fate and ER-Golgi Homeostasis Will be Examined.Israel
-
Cancer Institute and Hospital, Chinese Academy...RecruitingSafety Assessment of Concurrent Radiotherapy and Novel Systemic Therapy for Breast Cancer (RADIOCOM)Chemotherapeutic Toxicity | Radiotherapy; Complications | PARP Inhibitor | Immune Checkpoint Inhibitor | Trastuzumab | Breast Cancer, Familial Male | CDK4/6 Inhibitor | PertuzumabChina
-
Sun Yat-sen UniversityRecruitingSolid Tumor | Intestinal Flora | Immune Checkpoint InhibitorChina
-
University of Kansas Medical CenterRecruitingHMG-CoA Reductase Inhibitor ToxicityUnited States
-
Mario Negri Institute for Pharmacological ResearchFederico II University; IRCCS MultimedicaCompletedProton Pump Inhibitor | Primary CareItaly
-
American Thrombosis and Hemostasis NetworkTakeda; CSL Behring; OctapharmaCompletedHemophilia A | Hemophilia B | Hemophilia | Hemophilia A With Inhibitor | Haemophilia | Hemophilia B With Inhibitor | Haemophilia A Without Inhibitor | Haemophilia B Without InhibitorUnited States
-
Institut Mutualiste MontsourisInstitut CurieRecruitingCancer | Immune Checkpoint Inhibitor | Cardiovascular BiomarkersFrance
-
VA Office of Research and DevelopmentVHA Pharmacy Benefits Management Services VA Center For Medication SafetyCompletedEvaluation of the National Randomized Proton Pump Inhibitor De-prescribing (RaPPID) Program (RaPPID)Proton Pump InhibitorsUnited States
-
Groupe Hospitalier Pitie-SalpetriereVanderbilt University Medical CenterCompleted
-
Ospedale Santa Croce-Carle CuneoUnknownPlatelet Aggregation Inhibitors
-
Radboud University Medical CenterCompletedProton Pump Inhibitor | Inappropriate Drug Use | Discontinuation | E-healthNetherlands
-
Assiut UniversityUnknownProton Pump Inhibitor Allergy
-
Assiut UniversityUnknownProton Pump Inhibitor Allergy
-
Bursa Postgraduate HospitalCompletedContrast Agents and Oral Factor Xa InhibitorTurkey
-
Nantes University HospitalCompletedProton Pump Inhibitors | DeprescriptionFrance
-
Institut Mutualiste MontsourisRecruitingCancer | Cardiovascular Complication | Immune Checkpoint Inhibitor | Immune-related Adverse EventFrance
-
Second Affiliated Hospital, School of Medicine,...RecruitingCarotid Artery Plaque | Plaque, Atherosclerotic | Immune Checkpoint Inhibitors | Programmed Cell Death Protein 1 Inhibitor | Intimal Medial Thickness of Internal Carotid ArteryChina
-
Nantes University HospitalCompletedProton Pump Inhibitors | DeprescriptionFrance
-
Drexel UniversityCompletedInhibitory Control Training | GameifactionUnited States
-
American Thrombosis and Hemostasis NetworkGenentech, Inc.Active, not recruitingHemophilia A With Inhibitor | Hemophilia B With Inhibitor | Haemophilia A Without Inhibitor | Haemophilia B Without InhibitorUnited States
-
Catalyst BiosciencesCompletedHemophilia A | Hemophilia B | Hemophilia A With Inhibitor | Hemophilia B With Inhibitor | Hemophilia A Without Inhibitor | Hemophilia B Without InhibitorBulgaria, Russian Federation
-
Cancer Institute and Hospital, Chinese Academy...Peking University; Peking University Cancer Hospital & InstituteRecruitingMalignant Tumor | Positron Emission Tomography | Fibroblast Activation Protein InhibitorChina
-
Hellenic Cooperative Oncology GroupCompletedAutoimmune Diseases | Immunotherapy | Checkpoint InhibitorGreece
-
Ronald BuckanovichGenentech, Inc.RecruitingPARP Inhibitor | Platinum-Resistant Fallopian Tube Carcinoma | Platinum-Resistant Primary Peritoneal Carcinoma | Hedgehog InhibitorUnited States
-
Robert Bosch Gesellschaft für Medizinische Forschung...CompletedAnovulation | Cytochrome P450 CYP3A Enzyme Deficiency | Disorder Due Cytochrome P450 CYP2D6 VariantGermany
-
Zhongnan HospitalRecruitingMalignant Neoplasm | PET/CT | Fibroblast Activation Protein InhibitorChina
-
Rijnstate HospitalTerminatedCOPD Exacerbation | Enoximone | Phosphodiesterase InhibitorNetherlands
-
Northumbria UniversityPlant & food Research LtdCompletedPharmacodynamic Profile of 'Blackadder' Blackcurrant Juice Effects Upon the Monoamine Axis in HumansMonoamine Oxidase Inhibitor Activity | Prolactin Levels | Postprandial Blood Glucose
-
Universidad Vina del MarCompletedContraceptive Usage | Diffuse Noxious Inhibitory ControlChile
-
Fondation Ophtalmologique Adolphe de RothschildCompletedMEK Inhibitor-Associated Serous RetinopathyFrance
-
Samsung Medical CenterSuspendedAromatase (CYP19) Polymorphism Between AI-responsive and AI-resistant Breast Cancer in Korea (CYP19)Polymorphism | CYP19 | Aromatase InhibitorKorea, Republic of
-
Samsung Medical CenterCompletedAdherence, Medication | Percutaneous Coronary Intervention | Compliance, Medication | Platelet Aggregation Inhibitors | Hydroxymethylglutaryl-coa Reductase Inhibitors | Persistence, MedicationKorea, Republic of
-
Atsushi KawakamiGilead SciencesRecruitingRheumatoid Arthritis | Biomarker | JAK Inhibitor | Musculoskeletal Ultrasound | IL-6 InhibitorJapan
-
Duke UniversityCompletedAspirin | Platelet Aggregation Inhibitors | Ticagrelor | RNAUnited States
-
Radboud University Medical CenterCompletedCardiovascular Diseases | Muscle Damage | HMG COA Reductase Inhibitor Adverse ReactionNetherlands
-
Ege UniversityCompletedComposite Resins | Matrix Metalloproteinase Inhibitors
-
Sun Yat-sen UniversityUnknownHydroxymethylglutaryl-CoA Reductase Inhibitors | Endothelium